Santhera Pharmaceuticals Holding AG Share Price OTC Markets
Equities
SPHDF
CH1276028821
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 USD | +4.00% |
|
-.--% | -.--% |
06-19 | Transcript : Santhera Pharmaceuticals Holding AG - Special Call | |
06-18 | Santhera Secures CHF69 Million Financing for Bond Repayment, Cash Runway Extension | MT |
Sales 2024 * | 24M 26.78M 2.09B | Sales 2025 * | 60M 66.95M 5.23B | Capitalization | 76.39M 85.24M 6.66B |
---|---|---|---|---|---|
Net income 2024 * | -35M -39.05M -3.05B | Net income 2025 * | -10M -11.16M -872M | EV / Sales 2024 * | 3.18 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.27 x |
P/E ratio 2024 * |
-2.95
x | P/E ratio 2025 * |
-11.1
x | Employees | 45 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Santhera Pharmaceuticals Holding AG
1 day | +4.00% |
![Extreme 11.25](/images/extremecours_fleche.png)
![Extreme 9.4](/images/extremecours_fleche.png)
![Extreme 6.8](/images/extremecours_fleche.png)
![Extreme 6.8](/images/extremecours_fleche.png)
![Extreme 6.8](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 56 | 30/11/19 |
Thomas Meier
FOU | Founder | 62 | 06/09/04 |
Andrew Smith
DFI | Director of Finance/CFO | 61 | 31/03/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
FOU | Founder | 62 | 06/09/04 |
Director/Board Member | 56 | 03/04/17 | |
Otto Schwarz
BRD | Director/Board Member | 68 | 26/06/23 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.90% | 71.83B | |
+22.78% | 9.56B | |
+30.09% | 4.85B | |
-21.31% | 4.48B | |
+24.78% | 3.9B | |
+11.03% | 2.01B | |
-2.11% | 1.99B | |
-36.28% | 1.89B | |
-43.19% | 1.77B |
- Stock Market
- Equities
- SANN Stock
- SPHDF Stock